The index should top out soon, and experience a brief multi-day pullback to ideally around $14600+/-100 before rallying to $16600+.
For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the...
Q1-25 Revenue of € 144.1 Million and Net Income of € 31.5 MillionOrders of € 131.9 Million Up 8.2% vs....
Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity,...
On Wednesday, 30 April, at 13:00 (EEST), Liven AS CEO Andero Laur and CFO Joonas Joost will host a Webinar,...
New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between...
Image available: pr@jltmobile.com This announcement underscores JLT's long-term commitment to the port segment and their dedication to providing robust, reliable...
